Spectrum Pharmaceuticals Announces Record Revenues Results- Nasdaq:SPPI
Spectrum Pharmaceuticals, Inc. (Nasdaq:SPPI), a biotechnology firm with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, announced on...
View ArticleClik here to view.
Big time losers and the reasons why (STZ, SPPI, PMTC)
In this report: Constellation Brands (NYSE:STZ), Spectrum Pharmaceuticals (NASDAQ:SPPI) and Parametric Technology Corp. (NASDAQ:PMTC). Constellation Brands (NYSE:STZ) shares tanked over 13 percent...
View ArticleJazz Pharma (NASDAQ:JAZZ) Climbs Over 14% on $700M Agreement- JAZZ , DNDN,...
Shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) moved up on Friday following the Irish drug firm decided to purchase cancer drug maker EUSA Pharma for as much as $700 million. Jazz reported that it...
View ArticleAEterna Zentaris (NASDAQ:AEZS) Stock Hikes after FDA Deal – AEZS, MRK, SPPI, NVS
AEterna Zentaris Inc’s (USA) (NASDAQ:AEZS) stock moved up almost 20% on Friday after the Canadian drug manufacturer reported that it has agreed with United States rules on the design of a late-stage...
View ArticleVolume Gainers Watch List: XOMA (NASDAQ:XOMA), Spectrum Pharmaceuticals...
Tuesday’s trading session data confirmed that healthcare sector reacted positively and the major percentage gainer in sectors. BioScrip Inc (NASDAQ:BIOS) and Dynavax Technologies Corporation...
View ArticleReview of Key Percentage Decliners: Velti (NASDAQ:VELT), Spectrum...
Shares of Velti Plc (NASDAQ:VELT) plunged almost 30% to $2.18 in premarket trading session on Wednesday. Shares of the company tumbled as it swung to loss in fiscal fourth-quarter. The mobile marketing...
View ArticleLigand Pharmaceuticals Inc. (NASDAQ:LGND) and Spectrum Pharmaceuticals...
Ligand Pharmaceuticals Inc. (NASDAQ:LGND) inked a global licensing and supply agreement with Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI) to create Ligand’s Captisol-enabled melphalan for use as an...
View ArticleHealthcare Sector Top Decliners: Delcath, MannKind, BioCryst, InterMune,...
Shareholder rights attorneys at Robbins Arroyo LLP report that a shareholder of Delcath Systems, Inc (NASDAQ:DCTH) filed a federal securities fraud class action court case on May 8, 2013 in the United...
View Article
